Sutro Biopharma STRO Asset turnover
Asset turnover at other companies
Other financials
Where this comes from
Calculated from Sutro Biopharma’s reported figures.
Based on trailing twelve months.
The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sutro Biopharma's asset turnover.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sutro Biopharma's asset turnover?
- Sutro Biopharma (STRO) reported asset turnover of 0.4× in Q1 2026.
- How has Sutro Biopharma's asset turnover changed year-over-year?
- Sutro Biopharma's asset turnover increased by 92.9% year-over-year, from 0.2× to 0.4×.
- What is the long-term trend for Sutro Biopharma's asset turnover?
- Over 5 years (2020 to 2025), Sutro Biopharma's asset turnover has grown at a 18.7% compound annual growth rate (CAGR), from 0.2× to 0.4×.
- What does asset turnover mean?
- Trailing-twelve-month revenue divided by average total assets. Measures how many dollars of sales each dollar of assets generates — the efficiency leg of the DuPont decomposition of ROE.